*** Welcome to piglix ***

Biperiden

Biperiden
Biperiden Stereoisomers.png
Biperiden-3D-sticks.png
Clinical data
AHFS/Drugs.com Monograph
MedlinePlus a699058
Pregnancy
category
  • AU: B2
  • US: C (Risk not ruled out)
Routes of
administration
by mouth, IM, IV
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability 33 ± 5% (by mouth)
Protein binding 60%
Metabolism Liver hydroxylation
Biological half-life 18 to 24 hours
Excretion Kidney
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard 100.007.441
Chemical and physical data
Formula C21H29NO
Molar mass 311.461 g/mol
3D model (Jmol)
  

Biperiden, sold under the brandname Akineton among others, is a medication used to treat Parkinson disease and certain drug-induced movement disorders. It is not recommended for tardive dyskinesias. It is taken by mouth, injection into a vein, or muscle.

Common side effects include blurred vision, dry mouth, sleepiness, constipation, and confusion. It should not be used in people with a bowel obstruction or glaucoma. It is unclear if use in pregnancy or breastfeeding is safe. Biperiden is in the anticholinergic family of medication.

Biperiden was approved for medical use in the United States in 1959. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 1.52 to 12.92 USD per month. In the United States it costs about 50 to 100 USD per month.

Biperiden is used for the adjunctive treatment of all forms of Parkinson's disease and for reduced sweating in methadone users (postencephalitic, idiopathic, and arteriosclerotic). It seems to exert better effects in the postencephalitic and idiopathic than in the arteriosclerotic type.

Biperiden is also commonly used to improve parkinsonian signs and symptoms related to antipsychotic drug therapy, such as akathisia.


...
Wikipedia

...